Should testing be initiated prior to amoxicillin challenge in children?

Area of Science:

• Pediatric Allergy and Immunology
• Clinical Pharmacology
• Infectious Diseases

Background:

• Amoxicillin is a widely prescribed antibiotic in pediatric populations.
• A significant percentage of children are labeled with amoxicillin allergy, often inaccurately.
• Amoxicillin allergy labels are linked to negative health consequences, including antibiotic resistance.

Purpose of the Study:

• To review the strengths and limitations of current amoxicillin allergy assessment methods in children.
• To evaluate the role of skin testing versus drug provocation testing in pediatric amoxicillin allergy evaluations.
• To discuss the management of children with a history of immediate or non-immediate reactions to amoxicillin.

Main Methods:

• Narrative review of existing literature on amoxicillin allergy testing in children.
• Analysis of evidence supporting skin testing prior to drug provocation testing.
• Examination of data suggesting drug provocation testing may suffice for lower-risk children.

Main Results:

• The majority of children with a history of amoxicillin reaction tolerate the drug upon formal evaluation.
• Skin testing followed by drug provocation is a common diagnostic approach.
• Evidence is emerging for the safety and efficacy of drug provocation testing alone in select pediatric cases.

Conclusions:

• Accurate amoxicillin allergy evaluation is crucial to de-label children and prevent adverse health outcomes.
• The optimal diagnostic pathway, balancing skin testing and drug provocation, requires careful consideration.
• Further research may refine guidelines for assessing amoxicillin allergy in children, particularly for those at lower risk.